1. Home
  2. CADL vs LPA Comparison

CADL vs LPA Comparison

Compare CADL & LPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$5.02

Market Cap

357.4M

Sector

Health Care

ML Signal

HOLD

LPA

Logistic Properties of the Americas

HOLD

Current Price

$3.09

Market Cap

79.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
LPA
Founded
1999
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
357.4M
79.0M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
CADL
LPA
Price
$5.02
$3.09
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$19.00
N/A
AVG Volume (30 Days)
1.2M
20.3K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$11.25
Revenue Growth
N/A
N/A
52 Week Low
$4.25
$2.04
52 Week High
$7.24
$9.41

Technical Indicators

Market Signals
Indicator
CADL
LPA
Relative Strength Index (RSI) 50.33 57.06
Support Level $4.58 $3.05
Resistance Level $5.42 $3.33
Average True Range (ATR) 0.24 0.24
MACD 0.04 0.01
Stochastic Oscillator 75.63 44.51

Price Performance

Historical Comparison
CADL
LPA

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About LPA Logistic Properties of the Americas

Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has three operating segments, based on geographic regions, consisting of Colombia, Peru, and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.

Share on Social Networks: